HTA (Health technology assessment): how to benefit from the new realities
This article was originally published in Clinica
Health technology assessment is here to stay, as a glance at the burgeoning number of agencies and networks globally shows. Does this new reality simply represent an additional hurdle for manufacturers? If not where are the benefit? Consultant Mark Charny* provides a guide for companies coming to grips with how this fast-growing evaluation tool impacts their markets
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.